Malaysia Begins Phase 3 Trails Of China Developed COVID-19 Vaccine
Faizan Hashmi Published January 27, 2021 | 02:44 PM
Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (IMBCAMS), the Health Ministry said on Wednesday
KUALA LUMPUR, (APP - UrduPoint / Pakistan Point News - 27th Jan, 2021 ) :Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese academy of Medical Sciences (IMBCAMS), the Health Ministry said on Wednesday.
The initiative is a collaboration between the governments of Malaysia and China to generate scientific data in the development of the vaccine candidate to evaluate its safety and efficacy against COVID-19 infection, the ministry said in a statement.
The trials will involve nine government hospitals across Malaysia and 3,000 volunteers for a period of 13 months.
In his speech during the virtual launching ceremony, Malaysian Health Minister Adham Baba said Malaysia is very pleased to work with China, through IMBCAMS in contributing to the search for scientific evidence in the development of the inactivated vaccine.
"With strong regulatory, certified researchers and experienced research sites, we are confident of producing quality scientific evidence to support the research vaccine," he said.
"This cooperation will strengthen ties between China and Malaysia. I am very confident that we will have more opportunities to work together in the near future, bringing more positive results not only for both our countries, but also for the world," Adham said.
For his part, Che Yanchun, head of the R&D Department, Chinese Institute of Medical Sciences Academy of Medical Sciences, said Malaysia has been chosen as the first country outside China to participate in this phase 3 clinical trial of the COVID-19 vaccine which would also take place in other countries.
"I sincerely hope the phase 3 clinical trial in Malaysia will be a successful one, and it will fulfill the objectives of the clinical trial, and certainly Malaysia will also get the benefits from this trial," Che said.
Related Topics
Recent Stories
Naqvi directs foolproof measures for protection of Chinese nationals
Israel carries out attack inside Iran, report US media
Saudi Assistant Minister of Defence calls on army chief
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 19 April 2024
Today Gold Rate in Pakistan 19 April 2024
Rock-solid Ruud racks up season-leading win in Barcelona
At UN, Iran says it will make Israel 'regret' reprisals
G7 hears calls for 'critical' Ukraine aid
EU seeks to leverage might to confront China, US challenge
5 Customs officials martyred as their vehicle ambushed by terrorists in D I Khan
Pak-New Zealand match called off due to rain
NHA restores traffic on roads affected by recent rains in Balochistan
More Stories From World
-
Italy urges 'de-escalation' as G7 to discuss reported strike on Iran
10 minutes ago -
Indonesia on alert for more eruptions from remote volcano
10 minutes ago -
5.0-magnitude quake hits Alaska Peninsula
19 minutes ago -
Foreign-invested firms in China up 20.7 percent in Q1: data
19 minutes ago -
China launches digital database of classic graphics
19 minutes ago -
Hindu nationalist Modi the favourite as India votes
19 minutes ago
-
Two detained in Poland for attack on Navalny ally: Lithuania president
19 minutes ago -
International reactions after Israel's reported attack on Iran
20 minutes ago -
Eight killed in overnight Russian strikes, as Ukraine downs bomber
20 minutes ago -
Indonesia on alert for more eruptions at remote volcano
30 minutes ago -
Tokyo's Nikkei drops over 1,000 points, most in 3 years
30 minutes ago -
Oil jumps, equities fall as Iran blasts fan MidEast fears
30 minutes ago